Viatris Inc. (VTRS)

業務介紹

威瑞特斯公司(Viatris Inc.)在全球範圍內運營醫療保健業務。該公司分為四個業務部門:發達市場、大中華區、JANZ和新興市場。它提供處方品牌藥物、仿製藥、複雜仿製藥、生物類似藥和活性藥物成分(API)。該公司提供各種治療領域的藥物,包括非傳染性疾病和傳染性疾病;在腫瘤學、免疫學、內分泌學、眼科和皮膚科領域提供生物類似藥;以及用於抗菌、中樞神經系統藥物、抗組胺/抗哮喘藥、心血管藥物、抗病毒藥物、抗糖尿病藥物、抗真菌藥物和質子泵抑制劑領域的API,以及診斷診所、教育研討會和數字工具等支持服務,以幫助患者更好地管理自己的健康。該公司以口服固體劑型、注射劑、複雜劑型和API的形式向零售和藥房機構、批發商和分銷商、支付人、保險公司和政府以及機構提供藥品。該公司通過藥品批發商/分銷商、藥品零售商、機構藥房、郵購和電子商務藥房以及專科藥房分銷其產品。該公司銷售的產品包括Lyrica、Lipitor、Creon、Influvac、Wixela Inhub、EpiPen自動注射器、Fraxiparine和Yupelri;Norvasc和Viagra;AMITIZA、Lipacreon和Effexor;以及Celebrex和ARV等品牌,並提供包括Fulphila、Ogivri、Hulio和SEMGLEE在內的生物類似藥品牌。該公司與Revance Therapeutics, Inc.、Momenta Pharmaceuticals, Inc.、Theravance Biopharma, Inc.、Biocon Ltd.和富士フイルム協和キリン生物製薬株式會社有合作和許可協議。威瑞特斯公司成立於1961年,總部位於賓夕法尼亞州卡農斯堡。



Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

公司網址

https://www.viatris.com